| Sorafenib |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000118412.8 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000167912.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000177337.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000177788.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000179818.9 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000180139.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000183822.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000187156.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000203325.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000203325.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000204272.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000206337.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000213971.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000214347.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000214353.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000214401.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000214559.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000215498.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000223414.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000223461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000223573.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000223598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000223635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000223660.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000223695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000224037.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000224142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000224189.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000224281.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000224635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000224857.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000224905.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000224950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000224992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000225077.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000225092.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000225140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000225187.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000225857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000225929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000226291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000226752.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000226828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000227388.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000227486.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000227492.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000227906.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000228005.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000228028.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000228838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000228857.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000228865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000228939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000229267.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000229642.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000229874.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000229915.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000230074.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000230506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000230925.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000230928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000231010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000231025.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000231310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000231327.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000231329.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000231882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000231903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000232028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000232063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000232342.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000232411.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000232656.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000232828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000233029.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000233547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000233554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000234215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000234327.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000234571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000234753.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000235410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000235497.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000235586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000235880.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000236028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000236137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000236498.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000236859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000237200.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000237301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000237331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000237357.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000237359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000237436.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000237523.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000237919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000237976.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000239335.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000239569.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000239941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000240254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000240758.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000241481.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000241577.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000241818.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000241886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000242474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000243055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000243368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000244300.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000244380.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000244952.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000245059.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000245080.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000245614.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000246263.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000246582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000247324.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000247498.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000248416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000248445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000248516.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000248724.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000248936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000249492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000250027.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000250075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000250551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000250714.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000250751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000250751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000250786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000251164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000251175.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000251405.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000251523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000253167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000253369.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000253476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000253476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000253513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000253582.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000253636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000253708.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000253911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000253911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000253930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000254154.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000254419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000254554.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000255326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000255395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000255723.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000255989.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000256006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000256250.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000256299.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000256690.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000256789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000257086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000257354.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000257526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000257563.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000258181.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000258268.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000258285.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000258303.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000258354.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000258354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000258378.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000258704.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000258777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000259153.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000259188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000259209.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000259294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259353.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000259396.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000259488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259548.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000259635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259673.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000259709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000259713.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259768.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000259768.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259768.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000259772.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000259901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000259920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000259969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000259999.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000260006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000260132.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000260392.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000260447.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000260572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000260625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000260661.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000260742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000260920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000261000.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000261135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000261173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000261220.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000261254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000261441.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000261469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000261616.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000261673.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000261697.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000261839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000262171.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000263080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000263499.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000263727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000263727.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000263753.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000264196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000264673.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000264769.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000264895.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000265148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000265394.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000265458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000265478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000265485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000265490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000265490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000265666.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000265752.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000265791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000266456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000266473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000266579.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000266801.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000266803.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000266803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000266824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000266916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000266921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000266968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000266975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000266983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000267212.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000267272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000267374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000267416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000267474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000267480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000267499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000267575.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000267730.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000268201.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000268289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000268499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000268516.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000268530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000268536.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000268707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000268895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000269107.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000269400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000269423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000269938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000270009.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000270015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000270066.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000270069.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000270091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000270159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000270174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000271119.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000271204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000271228.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000271344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000271384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000271722.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000271732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000271882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000271882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000271931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000272144.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000272308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000272312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000272343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000272354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000272366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000272382.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000272446.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000272525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000272576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000272662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000272699.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000272721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000272791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000272800.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Sorafenib |
ENSG00000272815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000272911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
ENSG00000272945.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000273018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Sorafenib |
ENSG00000273061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Sorafenib |
ENSG00000273399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Sorafenib |
Lnc-VLDLR |
Curated lncRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-100 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-106b |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-122 |
Curated miRNA |
hepatocellular carcinoma |
|
| Sorafenib |
miR-126* |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-130a |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-130b |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-135a |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-136 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-146a |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-146b |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-148b |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-181a |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-181b |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-192 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-193b |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-193b |
Curated miRNA |
hepatocellular carcinoma |
|
| Sorafenib |
miR-196a |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-200c |
Curated miRNA |
clear-cell renal cell carcinoma |
|
| Sorafenib |
miR-206 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-216a |
Curated miRNA |
liver cancer |
|
| Sorafenib |
miR-217 |
Curated miRNA |
liver cancer |
|
| Sorafenib |
miR-222 |
Curated miRNA |
hepatocellular carcinoma |
|
| Sorafenib |
miR-224 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-27b |
Curated miRNA |
kidney cancer |
|
| Sorafenib |
miR-27b |
Curated miRNA |
liver cancer |
|
| Sorafenib |
miR-30a |
Curated miRNA |
renal cell carcinoma |
|
| Sorafenib |
miR-338 |
Curated miRNA |
hepatocarcinoma |
|
| Sorafenib |
miR-345 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-34a |
Curated miRNA |
hepatocellular carcinoma |
|
| Sorafenib |
miR-425 |
Curated miRNA |
hepatocellular carcinoma |
|
| Sorafenib |
miR-425* |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-483 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-548a |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-548c |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-551b |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-565 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-570 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-585 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-627 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-657 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-660 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-663 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-668 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-768 |
Curated miRNA |
hepatocellular cancer |
|
| Sorafenib |
miR-99b |
Curated miRNA |
hepatocellular cancer |
|
